1Koya D,George LK.Protein kinase Cactivation and the development of diabetic complications 〔J〕.Diabetes,1998,47：859～866.
2Morris AJ,Hammond SM,Colly C,et al.Regulation and functions of phospholipase D 〔J〕.BiochemSoc Trans,1997,25：1151～1157.
3Hammond SM,Altshuller YM,Sung TC,et al.Human ADP-ribosylation factor-activatedphosphatidylcholine-specific phospholipase D defines a new and highly conserved genefamily 〔J〕.J Biol Chem,1995,270：29640～29643.
4Ohguchi KY,Banno Y,Nakashima S,et al.Regulation of membrane-bound phospholipase Dby protein kinase C in HL60 cells.Synergistic action of small GTP-binding protein RhoA 〔J〕.JBiol Chem,1996,271：4366～4372.
5Exton JH.Phospholipase D：Enzymology,mechanisms of regulation,and function 〔J〕.PhysiolRev,1997,77：303～320.
6Ortmeyer J,Mohsenin V.Inhibition of phospholipase D and superoxide generation byglucose in diabetic neutrophils 〔J〕.Life Sci,1996,59：255～262.
7Xu JY,Botsford MW,Panagia V,et al.Responses of heart function and intracellularfree Ca2＋ to phosphatidic acid in chronic diabetes 〔J〕.Can J Cardiol,1996,12：1092～1098.
8Williams SA,Tappia PS,Yu CH,et al.Subcellular alterations in cardiac phospholipaseD activity in chronic diabetes 〔J〕.Pros Leukot Essent Fat Acids,1997,57：95～99.
9Williams SA,Tappia PS,Yu CH,et al.Impairment of the sarcolemmal phospholipaseD-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy 〔J〕.J Mol CellCardiol,1998,30：109～118.
10Natarajan V,Scribner WM,Hart CM,et al.Oxidized low density lipoprotein-mediatedactivation of phospholipase D in smooth muscle cells：a possible role in cellproliferation and atherogenesis 〔J〕.J Lipid Res,1995,36：2005～2016.
3Lunctta M,Infantone L,Calogero AE,et al.Increased urinary Albumin exereation is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus[J].Diabetes Res Clin Prac,1998,40(1):45.
